Xenco Medical is growing its international distribution hubs across the United Arab Emirates, the Kingdom of Saudi Arabia, Singapore, and the Sultanate of Oman. The strategic expansion brings the company’s next-generation biomimetic implants, regenerative biomaterials, and composite polymer surgical technologies to hospitals and surgeons throughout the Middle East and Southeast Asia.
Xenco Medical’s proprietary TrabeculeX Continuum platform harmonizes regenerative biomaterials with AI-powered post-surgical rehabilitation, enabling clinicians to monitor pain scores, patient adherence, and motion recovery through remote, AI-driven pose assessment.
“A testament to the universal resonance of our breakthrough technologies, we have been immensely excited by the enthusiastic embrace of Xenco Medical across global markets, demonstrating the ability of scientific advancements to traverse continents. We look forward to translating our growing presence in the Middle East and Southeast Asia into transformative patient outcomes,” said Xenco Medical Founder and CEO Jason Haider.
Xenco Medical is growing its international distribution hubs across the United Arab Emirates, the Kingdom of Saudi Arabia, Singapore, and the Sultanate of Oman. The strategic expansion brings the company's next-generation biomimetic implants, regenerative biomaterials, and composite polymer surgical technologies to hospitals and surgeons...
Xenco Medical is growing its international distribution hubs across the United Arab Emirates, the Kingdom of Saudi Arabia, Singapore, and the Sultanate of Oman. The strategic expansion brings the company’s next-generation biomimetic implants, regenerative biomaterials, and composite polymer surgical technologies to hospitals and surgeons throughout the Middle East and Southeast Asia.
Xenco Medical’s proprietary TrabeculeX Continuum platform harmonizes regenerative biomaterials with AI-powered post-surgical rehabilitation, enabling clinicians to monitor pain scores, patient adherence, and motion recovery through remote, AI-driven pose assessment.
“A testament to the universal resonance of our breakthrough technologies, we have been immensely excited by the enthusiastic embrace of Xenco Medical across global markets, demonstrating the ability of scientific advancements to traverse continents. We look forward to translating our growing presence in the Middle East and Southeast Asia into transformative patient outcomes,” said Xenco Medical Founder and CEO Jason Haider.
Copy to clipboard 
